Business
Press Release Dec 08 2021
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 08, 2021, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Selexipag Tablets, 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400 mcg, and 1,600 mcg".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 08, 2021, titled \"Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Selexipag Tablets, 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400 mcg, and 1,600 mcg\". View Attachment","length":450,"tagName":"div"}]